Evolution of Hematopoietic Cell Transplantation for Immunoglobulin Light Chain Amyloidosis | oneAMYLOIDOSISvoice
Scientific Articles

Evolution of Hematopoietic Cell Transplantation for Immunoglobulin Light Chain Amyloidosis

key information

source: Biology of Blood and Marrow Transplantation

year: 2016

authors: Sher T, Dispenzieri A, Gertz MA

summary/abstract:

Immunoglobulin light chain amyloidosis is the most common type of systemic amyloidosis. Hematopoietic stem cell transplantation (HCT) is an effective treatment option for AL however due to multi-organ involvement in this disease HCT is feasible in a minority of patients. To maximize the benefit and minimize toxicity it is of paramount importance to optimize the selection of patients for HCT. In this review we discuss evolution of HCT and its typical application to a case of AL amyloidosis.

organization: Mayo Clinic, USA

DOI: 10.1016/j.bbmt.2015.10.010

read more full text source

rareRelated

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close